Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Electronic interventions in primary care to address substance use: A systematic review

  • Villanueva-Blasco, Víctor J.
  • Eslava, Dalila
  • Olave, Leticia
  • Torrens, Marta
The present systematic review aims to identify electronic interventions for addressing substance use and understand their effectiveness in primary care settings. A systematic search was carried out in the Web of Science, PubMed/MEDLINE, Scopus, and Cochrane Library. The search included the keywords “electronic intervention”, “substance use”, “primary care” and synonyms. To determine the quality and recommendation of the analyzed interventions, the efficacy results reported by the studies were considered, as well as the Mixed Methods Appraisal Tool (MMAT) assessment and the GRADE Evidence Assessment. Twenty-one electronic interventions in Primary Care were identified: internet, mobile or tablet applications, text messages, emails, automated telephone calls, or electronic self-reports. These interventions had diverse components, incorporating theories that have proven effective in face-to-face interventions as their theoretical frameworks. Some of them were complementary to in-person treatment, while others replaced it. Six interventions (28.5 %) displayed high quality: HealthCall, AB-CASI, Quit Genius, eCHECKUP-TOGO, CBI, and TES. Another nine interventions (42.8 %) were found to have moderate-high quality: Alcohol y Salud, IVR-BI, Program of Wallace et al., Let’s Talk About Smoking, SMSalud, ESCAPE, AAC-ASPIRE, iQuit, and Programa VIH. One intervention (4.7 %) had moderate-low quality: Vive sin tabaco ¡Decídete! The remaining five interventions (23.8 %) were found to have very low quality: Connection to health, cSBI, Teen Well Check, the program of Helzer et al. (2008), and Down your drink. The programs with the highest recommendation for addressing alcohol-related issues are HealthCall and AB-CASI; for tobacco use, it is Quit Genius; for cannabis use, it is eCHECKUP-TOGO; for addressing both legal and illegal substances, it is CBI and TES. Finally, for specific illicit drug use, the only recommended program is CBI. This last intervention, CBI, is of the highest quality and, therefore, can be considered a model intervention for dissemination in the primary care setting.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Programas de prevención escolar del uso problemático de Internet, juego problemático y adicción a videojuegos en España: una revisión sistemática

  • Villanueva-Blasco, Víctor J.
  • Eslava, Dalila
  • Ibor Bernalte, Eduardo
  • Isorna Folgar, Manuel
  • Rial-Boubeta, Antonio
Con el presente trabajo se pretende identificar los programas de prevención escolar del Uso Problemático de Internet, Juego Problemático y Adicción a Videojuegos existentes en España, informando de sus características y de su eficacia, estableciendo diferentes grados de recomendación. Se llevó a cabo una revisión sistemática con dos estrategias complementarias: a) una búsqueda en los portales de Xchange, Buenas Prácticas en Adicciones (PPBB), Prevención Basada en la Evidencia y EDDRA; b) una búsqueda en Web of Science, PudMed/MEDLINE, APA PsycInfo, Scopus o Cochrane Library. La búsqueda incluyó las palabras clave “Spain”, “Gambling”, “Videogames”, “Internet”, “Social Network”, “School Prevention” y sinónimos. Se identificaron seis programas, de los cuales cinco disponían de estudios empíricos para evaluar su eficacia. Todos se fundamentaban en modelos teóricos relacionados con la etiología del problema, utilizaban una metodología activa e interactiva y eran implementados por profesionales con formación específica. Los programas ¿Qué te juegas?, Ludens y Safety.net alcanzaron un mayor grado de recomendación. Para los programas Cubilete y PrevTec 3.1. se sugieren estudios adicionales de su eficacia. Respecto a los portales de buenas prácticas, se sugiere priorizar la evidencia frente a la accesibilidad y señalar con claridad para qué problemática específica se ha demostrado eficaz cada programa. A partir de estos hallazgos se insiste en la necesidad de aportar evidencia empírica respecto a cualquier estrategia o programa de prevención. Se plantean finalmente algunas cuestiones de interés, como la conveniencia de contemplar la prevención de estas nuevas problemáticas de forma conjunta o por separado.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Abuse Potential of Cathinones in Humans, a Systematic Review

  • Poyatos, Lourdes|||0000-0002-4641-8600
  • Torres, Adrian
  • Papaseit, Esther|||0000-0003-2620-4274
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Hladun, Olga|||0000-0002-6230-5876
  • Núñez-Montero, Melani
  • Rosa, Georgina de la
  • Torrens, Marta
  • Fuster, Daniel|||0000-0003-1262-5860
  • Muga, Roberto|||0000-0001-6301-431X
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
Introduction and objective: Assessing the abuse potential of new substances with central nervous system activity is essential for preventing possible risks of misuse and addiction. The same methodology is recommended for the evaluation of the abuse potential of recreational drugs. This systematic review aims to assess the pharmacological effects related to the abuse potential and pharmacokinetics of cathinones, which are evaluated in both experimental and prospective observational studies in humans. Materials and Methods: A systematic search of the published literature was conducted to retrieve studies that had administered cathinone, mephedrone, methylone, and diethylpropion to evaluate their acute pharmacological effects related to abuse potential. Results: The search yielded 583 results, 18 of which were included to assess the abuse potential of cathinone (n = 5), mephedrone (n = 7), methylone (n = 1), and diethylpropion (n = 5). All four substances induce stimulant and euphorigenic effects that resemble those of amphetamines and MDMA, and their different intensities may be associated with varying levels of abuse potential. Conclusions: Cathinone, mephedrone, methylone, and diethylpropion induce a range of desirable and reinforcing effects that may, to some extent, result in abuse potential. Further investigation is needed to minimize and prevent their impact on society and public health.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Pharmacological effects of methylone and MDMA in humans

  • Poyatos, Lourdes|||0000-0002-4641-8600
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Hladun, Olga|||0000-0002-6230-5876
  • Núñez-Montero, Melani
  • Rosa, Georgina de la
  • Martín, Soraya|||0009-0008-3761-9217
  • Barriocanal, Ana María|||0000-0002-4159-519X
  • Carabias, Lydia
  • Kelmendi, Benjamin
  • Taoussi, Omayema
  • Busardo, Francesco Paolo|||0000-0002-3082-4532
  • Fonseca, Francina|||0000-0002-0779-6545
  • Torrens, Marta
  • Pichini, Simona
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Papaseit, Esther|||0000-0003-2620-4274
Methylone is one of the most common synthetic cathinones popularized as a substitute for 3,4-methylenedioxymethamphetamine (MDMA, midomafetamine) owing to its similar effects among users. Both psychostimulants exhibit similar chemistry (i.e., methylone is a β-keto analog of MDMA) and mechanisms of action. Currently, the pharmacology of methylone remains scarcely explored in humans. Herein, we aimed to evaluate the acute pharmacological effects of methylone and its abuse potential in humans when compared with that of MDMA following oral administration under controlled conditions. Seventeen participants of both sexes (14 males, 3 females) with a previous history of psychostimulant use completed a randomized, double-blind, placebo-controlled, crossover clinical trial. Participants received a single oral dose of 200 mg of methylone, 100 mg of MDMA, and a placebo. The variables included physiological effects (blood pressure, heart rate, oral temperature, pupil diameter), subjective effects using visual analog scales (VAS), the short form of the Addiction Research Center Inventory (ARCI), the Evaluation of Subjective Effects of Substances with Abuse Potential questionnaire (VESSPA-SSE), and the Sensitivity to Drug Reinforcement Questionnaire (SDRQ), and psychomotor performance (Maddox wing, psychomotor vigilance task). We observed that methylone could significantly increase blood pressure and heart rate and induce pleasurable effects, such as stimulation, euphoria, wellbeing, enhanced empathy, and altered perception. Methylone exhibited an effect profile similar to MDMA, with a faster overall onset and earlier disappearance of subjective effects. These results suggest that abuse potential of methylone is comparable to that of MDMA in humans. Clinical Trial Registration: ; Identifier: NCT05488171.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Multidimensional outcome of first-episode psychosis: a network analysis

  • Cuesta, Manuel J.
  • Gil Berrozpe, Gustavo José
  • Sánchez Torres, Ana María
  • Moreno-Izco, Lucía
  • García de Jalón, Elena
  • Peralta Martín, Víctor
  • SEGPEPs Group
Background Few studies have examined the long-term outcomes of first-episode psychosis (FEP) among patients beyond symptomatic and functional remission. This study aimed to broaden the scope of outcome indicators by examining the relationships between 12 outcomes of FEP patients at 20.9 years after their initial diagnosis. Methods At follow-up, 220 out of 550 original patients underwent a new assessment. Twelve outcomes were assessed via semistructured interviews and complementary scales: symptom severity, functional impairment, personal recovery, social disadvantage, physical health, number of suicide attempts, number of episodes, current drug use, dose-years of antipsychotics (DYAps), cognitive impairment, motor abnormalities, and DSM-5 final diagnosis. The relationships between these outcome measures were investigated using Spearman's correlation analysis and exploratory factor analysis, while the specific connections between outcomes were ascertained using network analysis. Results The outcomes were significantly correlated; specifically, symptom severity, functioning, and personal recovery showed the strongest correlations. Exploratory factor analysis of the 12 outcomes revealed two factors, with 11 of the 12 outcomes loading on the first factor. Network analysis revealed that symptom severity, functioning, social disadvantage, diagnosis, cognitive impairment, DYAps, and number of episodes were the most interconnected outcomes. Conclusion Network analysis provided new insights into the heterogeneity between outcomes among patients with FEP. By considering outcomes beyond symptom severity, the rich net of interconnections elucidated herein can facilitate the development of interventions that target potentially modifiable outcomes and generalize their impact on the most interconnected outcomes., Funding for the study came from the Gobierno de Navarra (grants 31/17 and 41/18), Ministerio de Economía, Industria y Competitividad de España (grants PI16/02148 and 19/01698), and Instituto de Salud Carlos III (ISCIII) (grant RD21/0009/0001),